Results 291 to 300 of about 134,036 (314)

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation Research, 2020
Peng Zhang, Lihua Zhu, jingjing cai
exaly  

The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts

Kidney International Supplements, 2022
Carlos M Ferrario, Leanne Groban, Xuming Sun   +2 more
exaly  

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19

Journal of the American Heart Association, 2021
Hanna Berlin, Tariq Azam, Erinleigh Michaud   +2 more
exaly  

The angiotensin receptor blockers

Journal of Cardiac Failure, 1999
openaire   +1 more source

β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure

Lancet, The, 2001
Duncan J Campbell, Murray Esler, David M Kaye   +2 more
exaly  

Renin-angiotensin system and cardiovascular risk

Lancet, The, 2007
Roland E Schmieder, Markus Schlaich, Karl Hilgers   +2 more
exaly  

Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension

Hypertension, 2020
Shaobin He
exaly  

Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity

Circulation, 2004
Thomas Unger, Ulrich Kintscher
exaly  

Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 2011
Sadashiva S Karnik
exaly  

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2004
Sten Madsbad
exaly